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Letter
NICE clinical guidelines
Authors' reply
EDITOR—Clinical guidelines are different when they are produced by the National Institute for
Clinical Excellence (NICE). NICE is an organisation charged with promoting the cost effective
use of limited NHS resources. Our experience, and that of many of our colleagues who have been
involved in the production of NICE clinical guidelines, is that the current processes do not
facilitate the appropriate consideration of cost effectiveness issues.
We believe that the process of guideline development requires adjustment. Whether the blame
for this lies with the health economics community or elsewhere, we share the hopes of Littlejohn
et al and Pilling et al that our editorial will prompt a constructive debate about the appropriate
methods for developing truly cost effective guidelines.
We do not claim that only health economists adopt a societal view, as Eccles says. Neither do we
suggest that ranked cost utility lists should be produced. We do, however, acknowledge the
scarcity of NHS resources and the need to compare options across NHS activities.
To date, guideline development groups have produced high quality guidelines, but these have
been based predominantly on clinical effectiveness considerations. Technology appraisals may
be imperfect, but they are an internationally reputed means for making health service policy
decisions underpinned by cost effectiveness analysis. Clinical guidelines and appraisals may be
different, but they also have common characteristics. The technology appraisal approach cannot
be translated lock, stock, and barrel, but many of its core elements are equally relevant to
guidelines.
Allan Wailoo, lecturer in health economics
a.j.wailoo@sheffield.ac.uk, Sheffield Health Economics Group, School of Health and Related
Research (ScHARR), University of Sheffield, Sheffield S1 4DA
Jennifer Roberts, senior lecturer in health economics, John Brazier, professor of health
economics, Chris McCabe, senior lecturer in health economics
Sheffield Health Economics Group, School of Health and Related Research (ScHARR),
University of Sheffield, Sheffield S1 4DA
Competing interests: The School of Health and Related Research receives funding from NICE
for work relating both to clinical guidelines and to technology appraisals.
